The Discounted Cash Flow (DCF) valuation of PTC Therapeutics Inc (PTCT) is 81.54 USD. With the latest stock price at 85.44 USD, the upside of PTC Therapeutics Inc based on DCF is -4.6%.
Based on the latest price of 85.44 USD and our DCF valuation, PTC Therapeutics Inc (PTCT) is a sell. selling PTCT stocks now will result in a potential gain of 4.6%.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 7.8% | 6.5% |
| Long-term Growth Rate | 3.0% - 4.9% | 3.9% |
| Fair Price | 34.19 - 988.67 | 81.54 |
| Upside | -60.0% - 1057.1% | -4.6% |